Image 1_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

“…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”

Image 4_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

“…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”

Image 8_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

“…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”

Image 10_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

“…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”

Image 2_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

“…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”

Summary of the data by season and region/district. by Wael Ghada (11719000)

Data Sheet 1_Genetic knockdown of DYRK1A attenuates cognitive impairment, Aβ pathology, tauopathy and neuroinflammatory responses in mouse models of AD.docx by Hyun-ju Lee (7550741)

“…Finally, hippocampal DYRK1A knockdown in PS19 mice [a model of AD that overexpresses human mutant tau (P301S)] selectively decreased insoluble tau hyperphosphorylation at Ser396 and Ser404 and alleviated proinflammatory responses/glial-associated neuroinflammatory dynamics. …”

Deletion of the <i>aspC</i> gene decreases the number of origins per cell and the decrease is reversed by extra AspC. by Feng Liu (72874)

Tranilast decreases RANKL-induced ROS level. by Tien Van Phan (583324)

Summary of age, breeding status and individual measurements of stranded Leach’s Storm-Petrels (<i>H</i>. <i>leucorhous</i>) collected during night surveys at the seafood processing... by Tori V. Burt (17261197)

Loss of Diva decreases cell number and viability. by Nicole Suyun Liu (311271)

Complex I inhibitor decreases LDH release by Zheng Li (26302)

RNA Environment Is Responsible for Decreased Photostability of Uracil by Sebastian Reiter (5496599)

RNA Environment Is Responsible for Decreased Photostability of Uracil by Sebastian Reiter (5496599)

RNA Environment Is Responsible for Decreased Photostability of Uracil by Sebastian Reiter (5496599)

RNA Environment Is Responsible for Decreased Photostability of Uracil by Sebastian Reiter (5496599)

Nicotine-induced Cell Migration is decreased by BEL. by Lindsay E. Calderon (332344)

Canagliflozin decreased body weight in DIO mice. by Wenjun Ji (822811)

RNA Environment Is Responsible for Decreased Photostability of Uracil by Sebastian Reiter (5496599)

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)